Total market is expected to grow XX over the forecast period and offering $ opportunity value of around USD XX million from 2023-2033.
The 9MMDiabetic Neuropathic Pain Treatment Market is expected to offer an $ opportunity of USD XX Million over the analysis period. Market was estimated USD XX Million during estimated year i.e. 2023 and expected to grow at a significant CAGR XX% over the projected period. And by the end of 2033, the market is expected to touch USD XX Million.
Diabetic neuropathic torment (DNP) is a kind of nerve torment that can found in people suffering from diabetes. An intricacy of diabetes influences the nerves, and it is frequently connected with fringe neuropathy, a typical long haul confusion of diabetes. Harm to the nerves can subsequently create difficult issues in different pieces of the body for individuals with type 1, type 2 or different kinds of diabetes.
Disease Burden Analysis:
Studies suggested that, nearly 50% of diabetes patients at some point in life time develop neuropathy
Diabetic polyneuropathy is the most common neuropathy in developed countries
The prevalence of PDN ranges from 10% to 20% of patients with diabetes and in those with diabetic neuropathy it ranges from 40% to 50%
The prevalence of peripheral neuropathy is estimated to be between 6% and 51% among adults with diabetes depending on age
Nearly 30% of all individuals with DPN will experience painful symptoms that will require pharmacological and other treatments
Report Insights:
More than 400 clinical trials, United States is the dominated region
Huge unmet need exists
20-25 molecules might witness the market by 2040 during forecast period
CSP Analytics Solutions provided the clinical mapping of key pipeline molecules
The 9MM Diabetic Neuropathic Pain Treatment Market is expected to offer an $ opportunity of USD XX Million over the analysis period. Market was estimated USD 1,823.5 Million during estimated year i.e. 2023 and expected to grow at a significant CAGR 6.21% over the projected period. And by 2033, the market is expected to touch USD XX Million.
Market Segmentation Analysis by:
By Treatment:
Analgesic
Opioid
NSAIDs
Anti-depressants
Anti-convulsant
Radiotherapy
Pipeline drugs
Others
By Therapy:
Nonpharmacological
Topical treatment
Combination therapy
Pharmacological
By Disorder Types:
Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy
By End User:
Hospitals
Clinics
Others
Market Dynamics: Explored in report
Surging Prevalence of Diabetic Neuropathic Pain Across Region
Growing Clinical Trial Activities
Huge Market Unmet Need
High Mortality Rate
Market Challenges: Explored in report
Lack of Efficacious Treatment Option
Cost of Treatment
Underdiagnoses in Emerging Market
Regional Outlook:
Report has fragmented the total market in five regions such as US, 5-Europe, China, Japan, India and RoW (Rest of world).
Each mapped region has been examined at granular level based on certain parameters:
United States
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
5-Europe
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
China
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
India
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
Japan
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
Rest of the World
Market Size and Forecast Model 2023-2033
Current Treatment Approaches
Key Opinion Leader (KOL)
Disease Burden Analysis (Prevalence, Diagnosed, Prevalent Pool Analysis)
Drug Share Analysis (%)
Current Treatment Landscape and Upcoming therapy Assessment
Reimbursement of Drugs
Market Unmet Need Analysis
Pipeline Drugs in the Region
Key Players in the Market and their Market share (%)
Competitive Landscape: Players in Market Space - Players explored in the report has been analyzed at various parameters. Analysis done around, product offerings, pipeline assets, In-licensing and out-licensing opportunities, financial health, market share, collaboration and partnership, patents, funding secures, technology outlook, future strategic move and investment.
Companies Profile:
Novaremed AG
Eli Lilly
Helixmith Co.
Pfizer
Aptinyx
Vernalis (R&D) Ltd
Haisco Pharmaceutical Group Co., Ltd.
Novartis Pharmaceuticals
Bayer
Glenmark Pharmaceuticals
Lexicon Pharmaceuticals
AbbVie
Swedish Orphan Biovitrum
Biogen
Daiichi Sankyo Co., Ltd.
Others
Pipeline molecules investigated in the report:
ABT-652
Novel A2A Agonist
RTA 901
LY3556050
HSK16149
EMA401
Others
Reason to buy this report:
Fostering Understanding on Diabetic Neuropathic Pain market
In Order to Understand the Market Potential
Opportunity Analysis (exist in the market for players)
